Alzamend Neuro earnings were -$8.8M for the trailing 12 months ending Apr 30, 2026, with N/A growth year over year. The latest ALZN earnings report on Apr 30, 2026 announced Q2 2026 earnings of -$2.9M, up 30.5% from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, ALZN reported annual earnings of -$8.8M, with 71.8% growth. The next ALZN earnings date is Sep 9, 2026.
Alzamend Neuro (NASDAQ: ALZN) reported Q1 2026 earnings per share (EPS) of -$0.74, up 58.43% year over year. Total ALZN earnings for the quarter were -$2.87 million. In the same quarter last year, Alzamend Neuro's earnings per share (EPS) was -$1.78.
The next ALZN earnings date is Sep 9, 2026. Add ALZN to your watchlist to be reminded of Alzamend Neuro's next earnings date.
Is Alzamend Neuro profitable or losing money?
As of the last Alzamend Neuro earnings report, Alzamend Neuro is currently losing money. Alzamend Neuro's net profit (also called net income) for the twelve months ending Apr 30, 2026 was -$8.77 million, a 94.3% increase year over year.
What was ALZN's earnings growth in the past year?
As of Alzamend Neuro's earnings date in Q3 2026, Alzamend Neuro's earnings has grown year over year. ALZN earnings in the past year totalled -$8.77 million.
What are Alzamend Neuro's earnings expectations?
The current EPS estimate for Alzamend Neuro's earnings report in Sep 9, 2026 is -$0.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.